Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment

被引:13
|
作者
Singhal, Aneesh B. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Neurol Dept, Boston, MA USA
[2] Massachusetts Gen Hosp, Neurol Dept, Boston, MA 02114 USA
关键词
Thunderclap headache; cerebral vasoconstriction; arteriopathy; LONG-TERM OUTCOMES; THUNDERCLAP HEADACHE; PRIMARY ANGIITIS; SUBARACHNOID HEMORRHAGE; HYPERINTENSE VESSELS; ANGIOPATHY; VASCULITIS; PATHOPHYSIOLOGY; ANGIOGRAPHY; FEATURES;
D O I
10.1177/17474930231181250
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Reversible segmental narrowing of the intracranial arteries has been described since several decades in numerous clinical settings, using variable nosology. Twenty-one years ago, we tentatively proposed the unifying concept that these entities, based on similar clinical-imaging features, represented a single cerebrovascular syndrome. This "reversible cerebral vasoconstriction syndrome" or RCVS has now come of age. A new International Classification of Diseases code, (ICD-10, I67.841) has been established, enabling larger-scale studies. The RCVS2 scoring system provides high accuracy in confirming RCVS diagnosis and excluding mimics such as primary angiitis of the central nervous system. Several groups have characterized its clinical-imaging features. RCVS predominantly affects women. Recurrent worst-ever (thunderclap) headaches are typical at onset. While initial brain imaging is often normal, approximately one-third to half develop complications such as convexity subarachnoid hemorrhages, lobar hemorrhages, ischemic strokes located in arterial "watershed" territories and reversible edema, alone or in combination. Vasoconstriction evolves over hours to days, first affecting distal and then the more proximal arteries. An overlap between RCVS and primary thunderclap headache, posterior reversible encephalopathy syndrome, Takotsubo cardiomyopathy, transient global amnesia, and other conditions has been recognized. The pathophysiology remains largely unknown. Management is mostly symptomatic: headache relief with analgesics and oral calcium-channel blockers, removal of vasoconstrictive factors, and avoidance of glucocorticoids that can significantly worsen outcome. Intra-arterial vasodilator infusions provide variable success. Overall, 90-95% of admitted patients achieve complete or major resolution of symptoms and clinical deficits within days to weeks. Recurrence is exceptional, although 5% can later develop isolated thunderclap headaches with or without mild cerebral vasoconstriction.
引用
收藏
页码:1151 / 1160
页数:10
相关论文
共 50 条
  • [41] RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome
    Rocha, Eva A.
    Topcuoglu, M. Akif
    Silva, Gisele S.
    Singhal, Aneesh B.
    NEUROLOGY, 2019, 92 (07) : e639 - e647
  • [42] Reversible Cerebral Vasoconstriction Syndrome: a Comprehensive Update
    Ali Mehdi
    Rula A. Hajj-Ali
    Current Pain and Headache Reports, 2014, 18
  • [43] Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations
    Pilato, Fabio
    Distefano, Marisa
    Calandrelli, Rosalinda
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [44] Reversible cerebral vasoconstriction syndrome: case report
    Oz, Oguzhan
    Demirkaya, Seref
    Bek, Semai
    Eroglu, Erdal
    Ulas, Uemit Hidir
    Odabasi, Zeki
    JOURNAL OF HEADACHE AND PAIN, 2009, 10 (04) : 295 - 298
  • [45] Reversible cerebral vasoconstriction syndrome in children: an update
    Maldonado-Soto, Angel R.
    Fryer, Robert H.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2021, 40
  • [46] Clinical Worsening in Reversible Cerebral Vasoconstriction Syndrome
    Katz, Brian S.
    Fugate, Jennifer E.
    Ameriso, Sebastian F.
    Pujol-Lereis, Virginia A.
    Mandrekar, Jay
    Flemming, Kelly D.
    Kallmes, David F.
    Rabinstein, Alejandro A.
    JAMA NEUROLOGY, 2014, 71 (01) : 68 - 73
  • [47] Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study
    Patel, Smit D.
    Topiwala, Karan
    Saini, Vasu
    Patel, Neel
    Pervez, Mubashir
    Al-Mufti, Fawaz
    Hassan, Ameer E.
    Khandelwal, Priyank
    Starke, Robert M.
    JOURNAL OF NEUROLOGY, 2021, 268 (02) : 632 - 639
  • [48] Centripetal Propagation of Vasoconstriction at the Time of Headache Resolution in Patients with Reversible Cerebral Vasoconstriction Syndrome
    Shimoda, M.
    Oda, S.
    Hirayama, A.
    Imai, M.
    Komatsu, F.
    Hoshikawa, K.
    Shigematsu, H.
    Nishiyama, J.
    Osada, T.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (09) : 1594 - 1598
  • [49] Narrative Review: Headaches After Reversible Cerebral Vasoconstriction Syndrome
    Yu-Hsiang Ling
    Shih-Pin Chen
    Current Pain and Headache Reports, 2020, 24
  • [50] Reversible Cerebral Vasoconstriction Syndrome Associated With Oxybutynin Use; a Brief Review of Pathophysiology
    Khan, Wahab J.
    Asif, Muhammad
    Aslam, Sadia
    Nadeem, Ifrah
    Rossing, William
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2023, 13 (04):